Planta Med 2012; 78(15): 1645-1650
DOI: 10.1055/s-0032-1315214
Natural Product Chemistry
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Acylated Iridoids from the Roots of Valeriana officinalis var. latifolia

Zhu-zhen Han
1   Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, PR China
2   Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai, PR China
,
Zhao-hui Yan
2   Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai, PR China
,
Qing-xin Liu
2   Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai, PR China
,
Xian-qing Hu
2   Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai, PR China
,
Ji Ye
2   Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai, PR China
,
Hui-liang Li
2   Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai, PR China
,
Wei-dong Zhang
1   Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, PR China
2   Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai, PR China
3   King Saud University, Riyadh, Saudi Arabia
4   School of Pharmacy, Shanghai Jiao Tong University, Shanghai, PR China
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 10. Februar 2012
revised 11. Juli 2012

accepted 17. Juli 2012

Publikationsdatum:
07. August 2012 (online)

Zoom Image

Abstract

Phytochemical investigation of the roots of Valeriana officinalis var. latifolia resulted in the isolation and characterization of six new acylated iridoids, (5S,7S,8S,9S)-7-hydroxy-8-isovaleroyloxy-Δ 4,11-dihyronepetalactone (1), (5S,7S,8S,9S)-7-hydroxy-10-isovaleroyloxy-Δ 4,11-dihyronepetalactone (2), (5S,8S,9S)-10-isovaleroyloxy-Δ 4,11-dihyronepetalactone (3), (5S,6S,8S,9R)-6-isovaleroyloxy-Δ 4,11-1,3-diol (4), (5S,6S,8S,9R)-1,3-isovaleroxy-Δ 4,11-1,3-diol (5), and (5S,6S,8S,9R)-3-isovaleroxy-6-isovaleroyloxy-Δ 4,11-1,3-diol (6). Their structures were determined mainly by 1D and 2D NMR spectroscopic techniques. We also report herein for the first time the single crystal X-ray structure of compound 1. In addition, the cytotoxic activities of compounds 1-6 were evaluated against A549 (human lung adenocarcinoma), HCT116 (human colon carcinoma), SK-BR-3 (human breast carcinoma), and HepG2 (human hepatoma) cell lines. Compound 6 showed weak cell growth inhibition of A549, HCT116, SK-BR-3, and HepG2 cells.

Supporting Information